[SCHEDULE 13G/A] Tyra Biosciences, Inc. SEC Filing
Janus Henderson Group plc reported beneficial ownership of 2,856,290 shares of Tyra Biosciences common stock, equal to 5.4% of the class, in a Schedule 13G/A filing. The statement shows 0 shares of sole voting or dispositive power and 2,856,290 shares of shared voting and shared dispositive power, indicating the reported interest is held collectively by related entities. The filing identifies the reporting person type as IA, HC and lists indirect subsidiaries (JHIUS, JHIUKL and JHIAIFML) as registered investment advisers furnishing advice to Managed Portfolios. A power of attorney authorizes named employees to prepare and file U.S. reporting forms on the group's behalf.
Janus Henderson Group plc ha dichiarato il possesso beneficiario di 2,856,290 azioni ordinarie di Tyra Biosciences, pari al 5.4% della classe, in un deposito Schedule 13G/A. La dichiarazione indica 0 azioni con potere di voto o dispositive esclusivo e 2,856,290 azioni con potere di voto e dispositive condiviso, segnalando che l'interesse riportato 猫 detenuto collettivamente da entit脿 correlate. Il deposito identifica il tipo di soggetto dichiarante come IA, HC e elenca le controllate indirette (JHIUS, JHIUKL e JHIAIFML) come consulenti d'investimento registrati che forniscono consulenza a Managed Portfolios. Una procura autorizza i dipendenti nominati a preparare e presentare i moduli di segnalazione USA per conto del gruppo.
Janus Henderson Group plc inform贸 la propiedad beneficiaria de 2,856,290 acciones ordinarias de Tyra Biosciences, equivalentes al 5.4% de la clase, en una presentaci贸n Schedule 13G/A. La declaraci贸n muestra 0 acciones con poder de voto o dispositivo exclusivo y 2,856,290 acciones con poder de voto y dispositivo compartido, lo que indica que el inter茅s declarado se mantiene colectivamente por entidades relacionadas. La presentaci贸n identifica el tipo de declarante como IA, HC y enumera subsidiarias indirectas (JHIUS, JHIUKL y JHIAIFML) como asesores de inversi贸n registrados que brindan asesor铆a a Managed Portfolios. Un poder autoriza a empleados nombrados a preparar y presentar formularios de reporte en EE. UU. en nombre del grupo.
Janus Henderson Group plc電� Schedule 13G/A 鞝滌稖靹滌棎靹� Tyra Biosciences 氤错喌欤� 2,856,290欤�(鞝勳泊 韥措灅鞀れ潣 5.4%)鞐� 雽�頃� 靾橃澋鞝� 靻岇湢甓岇潉 鞁犼碃頄堨姷雼堧嫟. 頃措嫻 鞁犼碃靹滊姅 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 0欤检澊瓿� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓岇澊 2,856,290欤检瀯鞚� 氇呾嫓頃橃棳 鞁犼碃霅� 歆�攵勳澊 甏�霠� 氩曥澑霌れ棎 鞚橅暣 歆戨嫧鞝侅溂搿� 氤挫湢霅橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�. 鞝滌稖靹滌棎電� 鞁犼碃鞛� 鞙犿槙鞚� IA, HC搿� 鞝侅嫓頃橁碃 臧勳爲 鞛愴殞靷摛(JHIUS, JHIUKL 氚� JHIAIFML)鞚� 霌彪霅� 韴瀽鞛愲靷 旮办灛頃橃棳 Managed Portfolios鞐� 鞛愲鞚� 鞝滉车頃滊嫟瓿� 氚濏様鞀惦媹雼�. 鞙勳瀯鞛レ潃 歆�鞝曤悳 歆侅洂霌れ澊 攴鸽９鞚� 雽�鞁犿暣 氙戈淡 鞁犼碃靹滊ゼ 鞛戩劚路鞝滌稖頃� 靾� 鞛堧弰搿� 甓岉暅鞚� 攵�鞐暕雼堧嫟.
Janus Henderson Group plc a d茅clar茅, dans un d茅p么t Schedule 13G/A, la propri茅t茅 b茅n茅ficiaire de 2,856,290 actions ordinaires de Tyra Biosciences, soit 5.4% de la cat茅gorie. La d茅claration indique 0 action avec pouvoir de vote ou d'ali茅nation exclusif et 2,856,290 actions avec pouvoir de vote et d'ali茅nation partag茅, ce qui signifie que l'int茅r锚t d茅clar茅 est d茅tenu collectivement par des entit茅s li茅es. Le d茅p么t identifie le type de d茅clarant comme IA, HC et liste des filiales indirectes (JHIUS, JHIUKL et JHIAIFML) en tant que conseillers en investissement enregistr茅s fournissant des conseils aux Managed Portfolios. Une procuration autorise des employ茅s nomm茅s 脿 pr茅parer et d茅poser les formulaires de d茅claration am茅ricains au nom du groupe.
Janus Henderson Group plc meldete in einer Schedule 13G/A-Angabe den wirtschaftlichen Besitz von 2,856,290 Aktien der Stammaktien von Tyra Biosciences, entsprechend 5.4% der Klasse. Die Erkl盲rung weist 0 Aktien mit alleinigem Stimm- oder Verf眉gungsrecht und 2,856,290 Aktien mit gemeinsamem Stimm- und Verf眉gungsrecht aus, was darauf hinweist, dass das gemeldete Interesse kollektiv von verbundenen Gesellschaften gehalten wird. Die Einreichung benennt den meldenden Personentyp als IA, HC und f眉hrt indirekte Tochtergesellschaften (JHIUS, JHIUKL und JHIAIFML) als registrierte Anlageberater auf, die Managed Portfolios beraten. Eine Vollmacht berechtigt namentlich genannte Mitarbeitende, im Namen der Gruppe US-Meldeformulare zu erstellen und einzureichen.
- Janus Henderson disclosed beneficial ownership of 2,856,290 shares, representing a reported 5.4% interest in TYRA common stock.
- Filing specifies shared voting and shared dispositive power of 2,856,290 shares with 0 shares of sole power, providing clear allocation of authority.
- The report identifies the reporting person type as IA, HC and names indirect subsidiaries (JHIUS, JHIUKL and JHIAIFML) as registered investment advisers, improving transparency.
- A documented power of attorney authorizes named employees to execute and amend U.S. reporting forms on behalf of Janus Henderson, clarifying filing authority.
- None.
Insights
Janus Henderson reports a material 5.4% holding in TYRA via shared voting and dispositive power.
The filing discloses 2,856,290 shares and explicitly allocates shared voting and shared dispositive power to the reporting group while showing no sole voting or dispositive power. Crossing the 5% threshold triggers public reporting and signals a visible institutional position. The classification as IA, HC and the identification of investment-adviser subsidiaries clarify the channels through which the position is managed. On its face, the disclosure is a routine institutional ownership report rather than an indication of control actions.
The Schedule 13G/A and attached power of attorney reflect centralized, compliant reporting by Janus Henderson subsidiaries.
The document names JHIUS, JHIUKL and JHIAIFML as indirect subsidiaries and includes a power of attorney granting authority to specific employees to file and amend U.S. disclosure forms. That structure supports coordinated compliance across entities and clarifies who may execute reporting obligations. The statement of shared voting and dispositive power is explicit and limits ambiguity about how the position is reported within the group.
Janus Henderson Group plc ha dichiarato il possesso beneficiario di 2,856,290 azioni ordinarie di Tyra Biosciences, pari al 5.4% della classe, in un deposito Schedule 13G/A. La dichiarazione indica 0 azioni con potere di voto o dispositive esclusivo e 2,856,290 azioni con potere di voto e dispositive condiviso, segnalando che l'interesse riportato 猫 detenuto collettivamente da entit脿 correlate. Il deposito identifica il tipo di soggetto dichiarante come IA, HC e elenca le controllate indirette (JHIUS, JHIUKL e JHIAIFML) come consulenti d'investimento registrati che forniscono consulenza a Managed Portfolios. Una procura autorizza i dipendenti nominati a preparare e presentare i moduli di segnalazione USA per conto del gruppo.
Janus Henderson Group plc inform贸 la propiedad beneficiaria de 2,856,290 acciones ordinarias de Tyra Biosciences, equivalentes al 5.4% de la clase, en una presentaci贸n Schedule 13G/A. La declaraci贸n muestra 0 acciones con poder de voto o dispositivo exclusivo y 2,856,290 acciones con poder de voto y dispositivo compartido, lo que indica que el inter茅s declarado se mantiene colectivamente por entidades relacionadas. La presentaci贸n identifica el tipo de declarante como IA, HC y enumera subsidiarias indirectas (JHIUS, JHIUKL y JHIAIFML) como asesores de inversi贸n registrados que brindan asesor铆a a Managed Portfolios. Un poder autoriza a empleados nombrados a preparar y presentar formularios de reporte en EE. UU. en nombre del grupo.
Janus Henderson Group plc電� Schedule 13G/A 鞝滌稖靹滌棎靹� Tyra Biosciences 氤错喌欤� 2,856,290欤�(鞝勳泊 韥措灅鞀れ潣 5.4%)鞐� 雽�頃� 靾橃澋鞝� 靻岇湢甓岇潉 鞁犼碃頄堨姷雼堧嫟. 頃措嫻 鞁犼碃靹滊姅 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 0欤检澊瓿� 瓿惦彊 鞚橁舶甓� 氚� 瓿惦彊 觳橂秳甓岇澊 2,856,290欤检瀯鞚� 氇呾嫓頃橃棳 鞁犼碃霅� 歆�攵勳澊 甏�霠� 氩曥澑霌れ棎 鞚橅暣 歆戨嫧鞝侅溂搿� 氤挫湢霅橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�. 鞝滌稖靹滌棎電� 鞁犼碃鞛� 鞙犿槙鞚� IA, HC搿� 鞝侅嫓頃橁碃 臧勳爲 鞛愴殞靷摛(JHIUS, JHIUKL 氚� JHIAIFML)鞚� 霌彪霅� 韴瀽鞛愲靷 旮办灛頃橃棳 Managed Portfolios鞐� 鞛愲鞚� 鞝滉车頃滊嫟瓿� 氚濏様鞀惦媹雼�. 鞙勳瀯鞛レ潃 歆�鞝曤悳 歆侅洂霌れ澊 攴鸽９鞚� 雽�鞁犿暣 氙戈淡 鞁犼碃靹滊ゼ 鞛戩劚路鞝滌稖頃� 靾� 鞛堧弰搿� 甓岉暅鞚� 攵�鞐暕雼堧嫟.
Janus Henderson Group plc a d茅clar茅, dans un d茅p么t Schedule 13G/A, la propri茅t茅 b茅n茅ficiaire de 2,856,290 actions ordinaires de Tyra Biosciences, soit 5.4% de la cat茅gorie. La d茅claration indique 0 action avec pouvoir de vote ou d'ali茅nation exclusif et 2,856,290 actions avec pouvoir de vote et d'ali茅nation partag茅, ce qui signifie que l'int茅r锚t d茅clar茅 est d茅tenu collectivement par des entit茅s li茅es. Le d茅p么t identifie le type de d茅clarant comme IA, HC et liste des filiales indirectes (JHIUS, JHIUKL et JHIAIFML) en tant que conseillers en investissement enregistr茅s fournissant des conseils aux Managed Portfolios. Une procuration autorise des employ茅s nomm茅s 脿 pr茅parer et d茅poser les formulaires de d茅claration am茅ricains au nom du groupe.
Janus Henderson Group plc meldete in einer Schedule 13G/A-Angabe den wirtschaftlichen Besitz von 2,856,290 Aktien der Stammaktien von Tyra Biosciences, entsprechend 5.4% der Klasse. Die Erkl盲rung weist 0 Aktien mit alleinigem Stimm- oder Verf眉gungsrecht und 2,856,290 Aktien mit gemeinsamem Stimm- und Verf眉gungsrecht aus, was darauf hinweist, dass das gemeldete Interesse kollektiv von verbundenen Gesellschaften gehalten wird. Die Einreichung benennt den meldenden Personentyp als IA, HC und f眉hrt indirekte Tochtergesellschaften (JHIUS, JHIUKL und JHIAIFML) als registrierte Anlageberater auf, die Managed Portfolios beraten. Eine Vollmacht berechtigt namentlich genannte Mitarbeitende, im Namen der Gruppe US-Meldeformulare zu erstellen und einzureichen.
FAQ
Who filed the Schedule 13G/A for TYRA?
How many Tyra Biosciences (TYRA) shares does Janus Henderson report owning?
What percentage of TYRA does the reported holding represent?
What voting and dispositive powers are reported by Janus Henderson?
Which subsidiaries are identified as involved in managing the position?
Who signed the Schedule 13G/A on behalf of Janus Henderson?
